SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Proceeds from (Repayments of) Related Party Debt
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Proceeds from (Repayments of) Related Party Debt of -$190.27 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2025-11-13
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. proceeds from (repayments of) related party debt for the quarter ending 2023-06-30 was -$139.23K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. proceeds from (repayments of) related party debt for the quarter ending 2023-03-31 was -$546.24K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. proceeds from (repayments of) related party debt for fiscal 2022 was -$50.00K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$190.27K 10-Q · filed 2025-11-13 | |||
| 2024-09-30 | $250.00K 10-Q · filed 2025-11-13 | |||
| 2023-06-30 | -$139.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$685.47K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | -$546.24K 10-Q · filed 2023-05-25 | |||
| 2022-12-31 | -$50.00K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |